MetLife (MET)’s “Neutral” Rating Reaffirmed by Zacks Investment Research Analysts – LocalizedUSA

MetLife (MET)'s "Neutral" Rating Reaffirmed by Zacks Investment Research Analysts
LocalizedUSA
individual life and non-medical health insurance products), Retirement Products (individual and institutional annuity products), Corporate Benefit Funding (pension closeouts, structured settlements and other benefit funding solutions),

and more »

More: continued here

Bookmark the permalink.

Leave a Reply